scholarly journals Stable growth transformation of human T lymphocytes by herpesvirus saimiri.

1992 ◽  
Vol 89 (7) ◽  
pp. 3116-3119 ◽  
Author(s):  
B. Biesinger ◽  
I. Muller-Fleckenstein ◽  
B. Simmer ◽  
G. Lang ◽  
S. Wittmann ◽  
...  
1995 ◽  
Vol 121 (S1) ◽  
pp. S17-S17
Author(s):  
B. Biesinger ◽  
H. Fickenscher ◽  
A. Knappe ◽  
E. Meinl ◽  
C. Murphy ◽  
...  

1998 ◽  
Vol 72 (4) ◽  
pp. 3138-3145 ◽  
Author(s):  
Michael S. Kraft ◽  
Golo Henning ◽  
Helmut Fickenscher ◽  
Doris Lengenfelder ◽  
Jürg Tschopp ◽  
...  

ABSTRACT Herpesvirus saimiri (HVS) transforms human T cells to stable growth in vitro. Since HVS codes for two different antiapoptotic proteins, growth transformation by HVS might be expected to confer resistance to apoptosis. We found that the expression of both viral antiapoptotic genes was restricted to cultures with viral replication and absent in growth-transformed human T cells. A comparative examination of HVS-transformed T-cell clones and their native parental clones revealed that the expression of Bcl-2, Bcl-XL, Bax, and members of the tumor necrosis factor receptor (TNF-R) superfamily with a death domain, namely, TNF-RI, CD95, and TRAMP, were not modulated by HVS. Expression of CD30 was induced in HVS-transformed T cells, and these cells also expressed the CD30 ligand. Uninfected and transformed T cells were sensitive to CD95 ligation but resistant to apoptosis mediated by TRAIL or soluble TNF-α. CD95 ligand was constitutively expressed on transformed but not uninfected parental T cells. Both cell types showed similar sensitivity to cell death induction or inhibition of T-cell activation mediated by irradiation, oxygen radicals, dexamethasone, cyclosporine, and prostaglandin E2. Altogether, this study strongly suggests that growth transformation by HVS is based not on resistance to apoptosis but, rather, on utilization of normal cellular activation pathways.


Lab on a Chip ◽  
2021 ◽  
Vol 21 (8) ◽  
pp. 1527-1539
Author(s):  
Xiaoou Ren ◽  
Anthony E. Getschman ◽  
Samuel Hwang ◽  
Brian F. Volkman ◽  
Thomas Klonisch ◽  
...  

Our skin-on-chip (SoC) model uniquely enabled quantitative studies of transendothelial and transepithelial migration of human T lymphocytes under mimicked inflammatory skin conditions and was used to test new drug candidates.


Author(s):  
Anzhela Malysheva ◽  
Angela Ivask ◽  
Casey L. Doolette ◽  
Nicolas H. Voelcker ◽  
Enzo Lombi

Sign in / Sign up

Export Citation Format

Share Document